Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific ANO1 DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A ENSG00000131620 Anoctamin 1, calcium activated chloride channel 11 70078302-70189528 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA032148 Uncertain Uncertain Nucleus but not nucleoli, Plasma membrane Mixed salivary gland: 83.4 ANO2 C12orf3, TMEM16B ENSG00000047617 Anoctamin 2, calcium activated chloride channel 12 5531869-5946232 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA036276 Uncertain Supportive Plasma membrane, Nucleus but not nucleoli Tissue enhanced 0 testis: 6.8 placenta: 4.0 ANO6 DKFZp313M0720, TMEM16F ENSG00000177119 Anoctamin 6 12 45215987-45440404 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038958 Uncertain Expressed in all adipose tissue: 61.6 ANO9 PIG5, TMEM16J, TP53I5 ENSG00000185101 Anoctamin 9 11 417933-442011 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039948 Uncertain Tissue enhanced 0 duodenum: 23.2;small intestine: 21.1 skin: 13.4 ANXA1 ANX1, LPC1 ENSG00000135046 Annexin A1 9 73151757-73170393 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011271, HPA011272, CAB013023, CAB035987, CAB058693 Supportive Supportive Plasma membrane, Cytoplasm, Nucleus but not nucleoli, Nuclear membrane Expressed in all esophagus: 5578.1 ANXA2 ANX2, ANX2L4, CAL1H, LIP2, LPC2D ENSG00000182718 Annexin A2 15 60347134-60402883 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004311 Uncertain Expressed in all esophagus: 280.9 ANXA6 ANX6 ENSG00000197043 Annexin A6 5 151100712-151157882 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002462, CAB005077, HPA009650 Supportive Expressed in all smooth muscle: 240.1 APCS MGC88159, PTX2, SAP ENSG00000132703 Amyloid P component, serum 1 159587825-159588865 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007817, HPA053294 Supportive Tissue enriched 22 liver: 1034.1 gallbladder: 47.3 APP AD1 ENSG00000142192 Amyloid beta (A4) precursor protein 21 25880550-26171128 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000157, HPA001462 Supportive Supportive Golgi apparatus, Vesicles Expressed in all cerebral cortex: 590.9 AQP1 CHIP28, CO ENSG00000240583 Aquaporin 1 (Colton blood group) 7 30911855-30925516 Blood group antigen proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001707, HPA019206 Supportive Supportive Plasma membrane Expressed in all kidney: 537.6 AQP10 ENSG00000143595 Aquaporin 10 1 154321090-154325325 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065947 Supportive Group enriched 8 duodenum: 45.6;small intestine: 32.2 fallopian tube: 4.6 AQP11 ENSG00000178301 Aquaporin 11 11 77589391-77610355 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042879 Uncertain Uncertain Nucleus but not nucleoli, Vesicles Tissue enhanced 0 duodenum: 17.0;small intestine: 15.5 adrenal gland: 5.8 AQP12A AQP12 ENSG00000184945 Aquaporin 12A 2 240691845-240698483 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA042216 Supportive Tissue enriched 86 pancreas: 29.1 duodenum: 0.3 AQP2 ENSG00000167580 Aquaporin 2 (collecting duct) 12 49950741-49958881 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046834 Supportive Tissue enriched 186 kidney: 296.5 testis: 1.5 AQP4 MIWC ENSG00000171885 Aquaporin 4 18 26852038-26865818 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005079, HPA014784, CAB058689 Supportive Supportive Supportive Plasma membrane, Cell Junctions Group enriched 14 cerebral cortex: 330.3;lung: 111.9 skeletal muscle: 16.0 AQP5 ENSG00000161798 Aquaporin 5 12 49961870-49965681 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065008 Supportive Tissue enhanced 0 salivary gland: 280.7;testis: 111.3 stomach: 42.3 AQP6 AQP2L ENSG00000086159 Aquaporin 6, kidney specific 12 49967194-49977139 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA015278 Supportive Tissue enriched 15 kidney: 17.8 cerebral cortex: 1.2 AQP8 ENSG00000103375 Aquaporin 8 16 25215731-25228940 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046259 Uncertain Group enriched 193 colon: 287.1;pancreas: 261.4;rectum: 126.5 smooth muscle: 1.1 BAK1 BAK, BCL2L7, CDN1 ENSG00000030110 BCL2-antagonist/killer 1 6 33572547-33580293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005029 Supportive Expressed in all duodenum: 23.3 BASP1 CAP-23, CAP23, NAP-22, NAP22 ENSG00000176788 Brain abundant, membrane attached signal protein 1 5 17065598-17276843 Cytoskeleton related proteins, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045218, HPA050333 Uncertain Supportive Plasma membrane Tissue enhanced 0 cerebral cortex: 200.3 tonsil: 76.0 BAX BCL2L4 ENSG00000087088 BCL2-associated X protein 19 48954815-48961798 Cancer-related genes, Mitochondrial proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004206, HPA027878 Supportive Expressed in all rectum: 65.8 BCL2L1 Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52 ENSG00000171552 BCL2-like 1 20 31664452-31723989 Cancer-related genes, Mitochondrial proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000105, HPA035734, CAB072801, CAB072802 Uncertain Supportive Mitochondria, Vesicles Expressed in all bone marrow: 68.3 BCL2L2 BCL-W, KIAA0271, PPP1R51 ENSG00000129473 BCL2-like 2 14 23298790-23311759 Cancer-related genes, Mitochondrial proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB040539 Uncertain Expressed in all cerebral cortex: 42.0 BCL2L2-PABPN1 ENSG00000258643 BCL2L2-PABPN1 readthrough 14 23306835-23325369 Cancer-related genes, Mitochondrial proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA000637 Uncertain Mixed testis: 10.2 BEST1 BEST, BMD, RP50, VMD2 ENSG00000167995 Bestrophin 1 11 61949821-61965515 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Mixed bone marrow: 15.4 BEST2 FLJ20132, VMD2L1 ENSG00000039987 Bestrophin 2 19 12751702-12758458 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046229 Uncertain Group enriched 9 colon: 12.6;rectum: 10.8;tonsil: 3.7 skin: 1.0 BNIP3 Nip3 ENSG00000176171 BCL2/adenovirus E1B 19kDa interacting protein 3 10 131966455-131981931 Cancer-related genes, Mitochondrial proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003015, CAB011676 Supportive Uncertain Cytoplasm Expressed in all pancreas: 36.0 BNIP3L BNIP3a, Nix ENSG00000104765 BCL2/adenovirus E1B 19kDa interacting protein 3-like 8 26382898-26505636 Cancer-related genes, Mitochondrial proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015652, CAB025371 Supportive Supportive Mitochondria, Nucleus but not nucleoli Expressed in all ovary: 100.8 BPI BPIFD1 ENSG00000101425 Bactericidal/permeability-increasing protein 20 38260149-38337505 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061284 Supportive Tissue enriched 85 bone marrow: 764.0 testis: 9.0 C6 ENSG00000039537 Complement component 6 5 41142234-41261438 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043823, CAB069427 Supportive Group enriched 7 fallopian tube: 46.6;liver: 211.2 heart muscle: 18.7 C8A ENSG00000157131 Complement component 8, alpha polypeptide 1 56854806-56918221 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 69 liver: 208.4 gallbladder: 3.0 CACFD1 C9orf7, D9S2135, flower ENSG00000160325 Calcium channel flower domain containing 1 9 133459965-133470848 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015280 Uncertain Uncertain Nucleus but not nucleoli Expressed in all stomach: 21.0 CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supportive Uncertain Golgi apparatus, Vesicles, Nucleus but not nucleoli Tissue enhanced 0 cerebral cortex: 7.9;stomach: 4.9 adrenal gland: 1.5 CACNA1C CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS ENSG00000151067 Calcium channel, voltage-dependent, L type, alpha 1C subunit 12 1970786-2697950 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039796 Supportive Tissue enhanced 0 heart muscle: 17.7;smooth muscle: 17.2 endometrium: 12.7 CACNA1F AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2 ENSG00000102001 Calcium channel, voltage-dependent, L type, alpha 1F subunit X 49205063-49233371 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed small intestine: 0.7 CACNA1H Cav3.2 ENSG00000196557 Calcium channel, voltage-dependent, T type, alpha 1H subunit 16 1153241-1221771 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA039125 Uncertain Tissue enhanced 0 ovary: 31.3 prostate: 16.3 CALCA CALC1 ENSG00000110680 Calcitonin-related polypeptide alpha 11 14966668-14972354 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 13 thyroid gland: 73.6 kidney: 5.7 CALHM1 FAM26C ENSG00000185933 Calcium homeostasis modulator 1 10 103453387-103458888 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018317 Uncertain Tissue enhanced 0 cerebral cortex: 0.8 tonsil: 0.4 CALHM2 FAM26B ENSG00000138172 Calcium homeostasis modulator 2 10 103446786-103452402 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014706 Uncertain Uncertain Nucleus but not nucleoli, Mitochondria, Cytoplasm Expressed in all ovary: 27.5 CALHM3 bA225H22.7, FAM26A ENSG00000183128 Calcium homeostasis modulator 3 10 103472804-103479240 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018205 Uncertain Uncertain Nucleus but not nucleoli Not detected testis: 0.2 CAMP CAP18, FALL-39, FALL39, LL37 ENSG00000164047 Cathelicidin antimicrobial peptide 3 48223347-48225491 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015949, CAB016522, HPA029874 Supportive Tissue enriched 202 bone marrow: 1070.6 salivary gland: 5.3 CATSPER3 CACRC ENSG00000152705 Cation channel, sperm associated 3 5 134967906-135011707 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 19 testis: 17.9 fallopian tube: 0.9 CATSPER4 ENSG00000188782 Cation channel, sperm associated 4 1 26190561-26202968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA045257 Supportive Tissue enriched 49 testis: 4.8 adipose tissue: 0.0 CATSPERB C14orf161, FLJ14298 ENSG00000133962 Catsper channel auxiliary subunit beta 14 91580696-91780707 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035134 Uncertain Uncertain Vesicles Tissue enhanced 0 gallbladder: 3.9 testis: 2.8 CATSPERD MGC39581, TMEM146 ENSG00000174898 Catsper channel auxiliary subunit delta 19 5720677-5778734 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA024056 Supportive Tissue enriched 78 testis: 7.7 adipose tissue: 0.0 CATSPERG C19orf15, DKFZp434A1022, FLJ46353 ENSG00000099338 Catsper channel auxiliary subunit gamma 19 38335775-38370943 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052777 Uncertain Tissue enriched 56 testis: 25.9 fallopian tube: 0.4 CAV3 LGMD1C, LQT9, VIP-21, VIP21 ENSG00000182533 Caveolin 3 3 8733800-8841808 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017518, CAB018557, HPA054488 Supportive Supportive Plasma membrane, Vesicles Group enriched 6 heart muscle: 11.5;skeletal muscle: 47.7 esophagus: 4.9 CCDC109B FLJ20647 ENSG00000005059 Coiled-coil domain containing 109B 4 109560205-109688726 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048776 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Mixed lymph node: 28.0 CHRNA1 CHRNA ENSG00000138435 Cholinergic receptor, nicotinic, alpha 1 (muscle) 2 174747592-174764472 Disease related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB010902, HPA071554 Uncertain Supportive Plasma membrane Tissue enhanced 0 prostate: 2.3;skeletal muscle: 5.6 tonsil: 0.9 CHRNA4 BFNC, EBN, EBN1 ENSG00000101204 Cholinergic receptor, nicotinic, alpha 4 (neuronal) 20 63343310-63378401 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB034064 Uncertain Tissue enhanced 0 cerebral cortex: 4.0;liver: 5.5;spleen: 3.0 kidney: 1.7 CHRNA7 ENSG00000175344 Cholinergic receptor, nicotinic, alpha 7 (neuronal) 15 32030488-32172521 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA029422, CAB033624 Supportive Mixed small intestine: 6.0 CHRNB1 CHRNB ENSG00000170175 Cholinergic receptor, nicotinic, beta 1 (muscle) 17 7445061-7457707 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA005822, CAB011200 Uncertain Expressed in all skeletal muscle: 33.5 CHRNB2 ENSG00000160716 Cholinergic receptor, nicotinic, beta 2 (neuronal) 1 154567781-154580026 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 11 cerebral cortex: 11.0 adrenal gland: 0.9 CHRND ACHRD ENSG00000135902 Cholinergic receptor, nicotinic, delta (muscle) 2 232525993-232536667 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 10 skeletal muscle: 6.9 prostate: 0.6 CHRNE ACHRE ENSG00000108556 Cholinergic receptor, nicotinic, epsilon (muscle) 17 4897774-4903074 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 52 heart muscle: 25.6 spleen: 0.4 CHRNG ACHRG ENSG00000196811 Cholinergic receptor, nicotinic, gamma (muscle) 2 232539727-232546403 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 16 skeletal muscle: 5.2 prostate: 0.3 CLCC1 MCLC ENSG00000121940 Chloride channel CLIC-like 1 1 108929508-108963457 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009087, HPA013210 Supportive Supportive Endoplasmic reticulum Expressed in all thyroid gland: 18.7 CLDN15 ENSG00000106404 Claudin 15 7 101232092-101238820 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 16 duodenum: 169.1;small intestine: 121.5 colon: 8.9 CLDN16 HOMG3, PCLN1 ENSG00000113946 Claudin 16 3 190322541-190412143 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA056020 Supportive Tissue enriched 5 kidney: 30.9 thyroid gland: 6.1 CLDN19 ENSG00000164007 Claudin 19 1 42733093-42740254 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 77 kidney: 18.7;placenta: 9.9 adipose tissue: 0.1 CLDN22 CLDN21 ENSG00000177300 Claudin 22 4 183318194-183320774 Predicted membrane proteins, Transporters Evidence at transcript level No evidence Evidence at transcript level Not detected esophagus: 0.1 CLDN23 CLDNL ENSG00000253958 Claudin 23 8 8701938-8704106 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 colon: 22.3;stomach: 20.1 rectum: 10.9 CLDN4 CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8 ENSG00000189143 Claudin 4 7 73799542-73832693 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002610, HPA007322 Supportive Supportive Plasma membrane Mixed colon: 188.4 CLDN7 CEPTRL2, CPETRL2, Hs.84359 ENSG00000181885 Claudin 7 17 7259903-7263983 Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013063, HPA014703 Supportive Mixed colon: 234.0 CLDN8 ENSG00000156284 Claudin 8 21 30214006-30216073 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA060605 Uncertain Tissue enhanced 0 kidney: 50.4;rectum: 43.1 colon: 27.9 CLIC1 NCC27, p64CLCP ENSG00000213719 Chloride intracellular channel 1 6 31730581-31739763 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020825, CAB040557 Supportive Supportive Cytoplasm Expressed in all rectum: 336.9 CLIC2 XAP121 ENSG00000155962 Chloride intracellular channel 2 X 155276211-155334657 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA060101 Uncertain Expressed in all spleen: 34.2 CLIC3 ENSG00000169583 Chloride intracellular channel 3 9 136994635-136996803 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005963 Uncertain Supportive Nucleus, Cytoplasm Tissue enhanced 0 esophagus: 62.7;thyroid gland: 50.1 placenta: 35.7 CLIC4 CLIC4L, DKFZP566G223, H1, huH1, P64H1 ENSG00000169504 Chloride intracellular channel 4 1 24745357-24844324 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008019, HPA060804 Supportive Supportive Cytoplasm Expressed in all smooth muscle: 222.7 CLIC5 ENSG00000112782 Chloride intracellular channel 5 6 45898451-46080395 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lung: 74.5;skeletal muscle: 92.9 heart muscle: 63.0 CLIC6 CLIC1L, CLIC5 ENSG00000159212 Chloride intracellular channel 6 21 34669389-34718227 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA055123, HPA065285 Uncertain Tissue enhanced 0 stomach: 46.2 fallopian tube: 12.8 CLNS1A CLCI, ICln ENSG00000074201 Chloride channel, nucleotide-sensitive, 1A 11 77514936-77637805 Cytoskeleton related proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017840, HPA031707, HPA031708, HPA032045 Uncertain Supportive Nucleus, Cytoplasm, Cytoskeleton (Microtubules) Expressed in all tonsil: 85.6 CMTM7 CKLFSF7, FLJ30992 ENSG00000153551 CKLF-like MARVEL transmembrane domain containing 7 3 32391671-32483067 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Expressed in all fallopian tube: 42.1 CNGA1 CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49 ENSG00000198515 Cyclic nucleotide gated channel alpha 1 4 47935977-48016672 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059734 Uncertain Nucleus, Nucleoli, Plasma membrane, Cytoplasm Mixed liver: 6.6 CNGA3 ACHM2, CCNC1, CCNCa, CNCG3, CNG3 ENSG00000144191 Cyclic nucleotide gated channel alpha 3 2 98346155-98398601 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed esophagus: 1.3 CNGB1 CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45 ENSG00000070729 Cyclic nucleotide gated channel beta 1 16 57882340-57971116 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039159, HPA060355 Uncertain Tissue enhanced 0 adrenal gland: 1.2;cerebral cortex: 0.7 testis: 0.3 CSTB CST6, EPM1, PME, STFB ENSG00000160213 Cystatin B (stefin B) 21 43772512-43776445 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017380, CAB047318, CAB047320, HPA058557 Supportive Supportive Nucleus, Nucleoli, Cytoplasm Tissue enriched 7 esophagus: 1363.3 tonsil: 207.9 DCD AIDD, DCD-1, DSEP, HCAP, PIF ENSG00000161634 Dermcidin 12 54644591-54648493 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 22 skeletal muscle: 2.4 skin: 0.1 DEFA1 DEF1, DEFA2, HNP-1, MRS ENSG00000206047 Defensin, alpha 1 8 6977649-6980080 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB032548, HPA052517 Supportive Tissue enriched 601 bone marrow: 17289.6 spleen: 28.7 DEFA1B ENSG00000240247 Defensin, alpha 1B 8 6996766-7018289 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA052517 Supportive Tissue enriched 411 bone marrow: 13617.2 spleen: 33.1 DEFA6 DEF6, HD-6 ENSG00000164822 Defensin, alpha 6, Paneth cell-specific 8 6924693-6926076 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019462 Supportive Group enriched 378 duodenum: 4523.7;small intestine: 7629.4 colon: 16.0 DEFB1 BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822 ENSG00000164825 Defensin, beta 1 8 6870575-6878022 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 kidney: 835.6;salivary gland: 266.3 liver: 92.1 DEFB103A DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3 ENSG00000176797 Defensin, beta 103A 8 7881204-7882664 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 skin: 0.6;tonsil: 2.2 esophagus: 0.4 DEFB103B ENSG00000177243 Defensin, beta 103B 8 7428888-7430348 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 skin: 0.7;tonsil: 2.2 esophagus: 0.4 DEFB4A DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1 ENSG00000171711 Defensin, beta 4A 8 7894629-7896711 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 esophagus: 4.8;gallbladder: 9.2;tonsil: 10.9 appendix: 1.0 DEFB4B DEFB4P ENSG00000177257 Defensin, beta 4B 8 7414860-7416863 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 18 esophagus: 2.8;gallbladder: 4.4;tonsil: 6.2 skin: 0.2 DYSF FER1L1, LGMD2B ENSG00000135636 Dysferlin 2 71453722-71686768 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002510, HPA017071, HPA021945 Supportive Mixed skeletal muscle: 23.6 ERVW-1 ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW ENSG00000242950 Endogenous retrovirus group W, member 1 7 92468380-92477986 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 28 placenta: 54.1 testis: 1.9 FAM26D C6orf78, FLJ32239 ENSG00000164451 Family with sequence similarity 26, member D 6 116529032-116558868 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019178, HPA048014 Uncertain Tissue enriched 49 placenta: 16.2 testis: 0.3 FXYD2 ATP1G1, HOMG2, MGC12372 ENSG00000137731 FXYD domain containing ion transport regulator 2 11 117800844-117828698 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004649, HPA068838 Supportive Tissue enhanced 0 gallbladder: 363.6;kidney: 1240.4;salivary gland: 418.6 pancreas: 135.6 FXYD5 OIT2 ENSG00000089327 FXYD domain containing ion transport regulator 5 19 35154730-35169883 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010817 Uncertain Uncertain Endoplasmic reticulum Expressed in all tonsil: 149.5 FXYD6 ENSG00000137726 FXYD domain containing ion transport regulator 6 11 117820075-117877486 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041334, HPA068838 Supportive Expressed in all cerebral cortex: 365.6 GABARAP ATG8A, MM46 ENSG00000170296 GABA(A) receptor-associated protein 17 7240014-7242770 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all ovary: 490.3 GABRA2 ENSG00000151834 Gamma-aminobutyric acid (GABA) A receptor, alpha 2 4 46248427-46475230 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 8 cerebral cortex: 40.4 small intestine: 5.2 GABRB2 ENSG00000145864 Gamma-aminobutyric acid (GABA) A receptor, beta 2 5 161288429-161549044 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001964, HPA067632 Supportive Tissue enriched 14 cerebral cortex: 34.6 spleen: 2.4 GAP43 B-50, PP46 ENSG00000172020 Growth associated protein 43 3 115623324-115721490 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004417, HPA013392, HPA015600 Supportive Tissue enriched 30 cerebral cortex: 188.8 appendix: 6.2 GJA3 CX46, CZP3 ENSG00000121743 Gap junction protein, alpha 3, 46kDa 13 20138255-20161049 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 heart muscle: 4.0;placenta: 2.4 testis: 1.3 GJA4 CX37 ENSG00000187513 Gap junction protein, alpha 4, 37kDa 1 34792998-34795747 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA047981 Uncertain Tissue enhanced 0 placenta: 47.9 fallopian tube: 31.2 GJA8 CAE, CAE1, CX50, CZP1 ENSG00000121634 Gap junction protein, alpha 8, 50kDa 1 147907956-147909257 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 51 testis: 5.0 adipose tissue: 0.0 GJB1 CMTX, CMTX1, CX32 ENSG00000169562 Gap junction protein, beta 1, 32kDa X 71215194-71225516 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010663, CAB012994 Supportive Tissue enhanced 0 liver: 132.2 gallbladder: 37.4 GJB2 CX26, DFNA3, DFNB1, NSRD1 ENSG00000165474 Gap junction protein, beta 2, 26kDa 13 20187470-20192898 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013093 Uncertain Tissue enriched 7 esophagus: 544.2 tonsil: 77.0 GJC3 CX30.2, GJE1 ENSG00000176402 Gap junction protein, gamma 3, 30.2kDa 7 99923269-99929620 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015024 Uncertain Tissue enhanced 0 prostate: 3.0 pancreas: 1.4 GLRA1 STHE ENSG00000145888 Glycine receptor, alpha 1 5 151822513-151924842 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level HPA016502 Uncertain Not detected adrenal gland: 0.1 GLRA2 GLR ENSG00000101958 Glycine receptor, alpha 2 X 14529298-14731812 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB070422 Supportive Group enriched 15 cerebral cortex: 3.3;colon: 1.5;rectum: 3.0 placenta: 0.1 GLRA3 ENSG00000145451 Glycine receptor, alpha 3 4 174636914-174829314 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 7 cerebral cortex: 4.8 adrenal gland: 0.6 GLRB ENSG00000109738 Glycine receptor, beta 4 157076057-157172090 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052363 Uncertain Tissue enhanced 0 cerebral cortex: 32.2 salivary gland: 9.7 GNLY D2S69E, LAG-2, LAG2, NKG5, TLA519 ENSG00000115523 Granulysin 2 85685175-85698854 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025186, HPA058021 Supportive Tissue enhanced 0 bone marrow: 121.3 endometrium: 49.1 GRIA2 GluA2, GLUR2, GLURB ENSG00000120251 Glutamate receptor, ionotropic, AMPA 2 4 157204182-157366075 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006830, CAB007812, HPA008441, CAB012981 Supportive Tissue enriched 6 cerebral cortex: 98.2 fallopian tube: 15.8 GRIA3 GluA3, GLUR3, GLURC, MRX94 ENSG00000125675 Glutamate receptor, ionotropic, AMPA 3 X 123184153-123490915 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058659 Uncertain Supportive Nucleus but not nucleoli, Plasma membrane Tissue enhanced 0 cerebral cortex: 29.7 adrenal gland: 7.0 GRIK4 GluK4, GRIK, KA1 ENSG00000149403 Glutamate receptor, ionotropic, kainate 4 11 120511759-120988904 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 5.3 ovary: 1.8 GRIN1 GluN1, NMDAR1 ENSG00000176884 Glutamate receptor, ionotropic, N-methyl D-aspartate 1 9 137138390-137168762 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB006831 Uncertain Tissue enriched 216 cerebral cortex: 71.9 prostate: 0.3 GRIN2C GluN2C, NMDAR2C ENSG00000161509 Glutamate receptor, ionotropic, N-methyl D-aspartate 2C 17 74842023-74861504 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 8 cerebral cortex: 4.3;heart muscle: 4.6;placenta: 1.5;salivary gland: 4.5;testis: 1.9;thyroid gland: 7.0 adrenal gland: 0.5 HCN2 BCNG-2, BCNG2, HAC-1 ENSG00000099822 Hyperpolarization activated cyclic nucleotide-gated potassium channel 2 19 589893-617159 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 15.6;heart muscle: 5.2 testis: 1.8 HCN4 ENSG00000138622 Hyperpolarization activated cyclic nucleotide-gated potassium channel 4 15 73319859-73369264 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 heart muscle: 1.2;testis: 4.0 cerebral cortex: 0.6 HPX ENSG00000110169 Hemopexin 11 6431049-6442617 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016725 Supportive Tissue enriched 2376 liver: 1577.6 prostate: 0.6 HSPA1A HSP70-1, HSPA1 ENSG00000204389 Heat shock 70kDa protein 1A 6 31815464-31817946 Cancer-related genes, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB017451, CAB032815, HPA052504 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all adrenal gland: 369.9 HSPA1B HSP70-2 ENSG00000204388 Heat shock 70kDa protein 1B 6 31827735-31830255 Cancer-related genes, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB008640, HPA052504 Uncertain Supportive Cytoplasm Expressed in all adrenal gland: 357.8 HTN3 HIS2 ENSG00000205649 Histatin 3 4 70028413-70036538 Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB073541 Supportive Uncertain Vesicles Tissue enriched 3248 salivary gland: 96796.7 pancreas: 29.8 HTR3A 5-HT3A, 5-HT3R, HTR3 ENSG00000166736 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 11 113974881-113990313 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 appendix: 1.8;lymph node: 5.4;tonsil: 6.6 small intestine: 0.8 HTR3D ENSG00000186090 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic 3 184031544-184039369 Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level Not detected adipose tissue: 0.0 HVCN1 Hv1, MGC15619, VSOP ENSG00000122986 Hydrogen voltage-gated channel 1 12 110627841-110704950 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039329 Uncertain Tissue enhanced 0 tonsil: 60.7 lymph node: 54.1 ITPR1 ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29 ENSG00000150995 Inositol 1,4,5-trisphosphate receptor, type 1 3 4493348-4847840 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014765, HPA016487 Supportive Uncertain Vesicles Mixed thyroid gland: 24.6 KCNA2 HK4, Kv1.2 ENSG00000177301 Potassium voltage-gated channel, shaker-related subfamily, member 2 1 110593580-110631474 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001976 Uncertain Group enriched 5 cerebral cortex: 8.5;thyroid gland: 2.2 tonsil: 1.0 KCNA3 HLK3, HPCN3, Kv1.3, MK3 ENSG00000177272 Potassium voltage-gated channel, shaker-related subfamily, member 3 1 110672465-110675033 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016625 Uncertain Mixed lymph node: 6.7 KCNA5 HK2, HPCN1, Kv1.5 ENSG00000130037 Potassium voltage-gated channel, shaker-related subfamily, member 5 12 5043989-5046788 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021516, CAB022562 Supportive Group enriched 5 esophagus: 4.0;heart muscle: 12.6 adipose tissue: 1.5 KCNB1 Kv2.1 ENSG00000158445 Potassium voltage-gated channel, Shab-related subfamily, member 1 20 49363877-49482647 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001979, HPA042434 Supportive Tissue enhanced 0 adipose tissue: 7.2;cerebral cortex: 10.8 fallopian tube: 4.7 KCNC3 Kv3.3, SCA13 ENSG00000131398 Potassium voltage-gated channel, Shaw-related subfamily, member 3 19 50311937-50333515 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018041 Uncertain Mixed fallopian tube: 9.5 KCND2 KIAA1044, Kv4.2, RK5 ENSG00000184408 Potassium voltage-gated channel, Shal-related subfamily, member 2 7 120273668-120750331 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029068 Uncertain Tissue enhanced 0 cerebral cortex: 11.0 gallbladder: 3.2 KCND3 KSHIVB, Kv4.3, SCA19, SCA22 ENSG00000171385 Potassium voltage-gated channel, Shal-related subfamily, member 3 1 111770662-111989155 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029452 Uncertain Mixed cerebral cortex: 13.7 KCNF1 IK8, KCNF, kH1, Kv5.1 ENSG00000162975 Potassium voltage-gated channel, subfamily F, member 1 2 10911937-10914225 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB004678, HPA014738 Supportive Uncertain Golgi apparatus Tissue enriched 26 cerebral cortex: 17.0 endometrium: 0.6 KCNH2 erg1, HERG, Kv11.1, LQT2 ENSG00000055118 Potassium voltage-gated channel, subfamily H (eag-related), member 2 7 150944961-150978315 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006838, HPA040783, HPA056584 Uncertain Tissue enhanced 0 bone marrow: 21.1;testis: 18.8 heart muscle: 7.1 KCNH3 BEC1, elk2, Kv12.2 ENSG00000135519 Potassium voltage-gated channel, subfamily H (eag-related), member 3 12 49539157-49558308 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051088 Uncertain Group enriched 6 cerebral cortex: 10.8;fallopian tube: 4.4 testis: 1.3 KCNJ1 Kir1.1, ROMK1 ENSG00000151704 Potassium inwardly-rectifying channel, subfamily J, member 1 11 128836315-128867373 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA026962 Supportive Tissue enriched 146 kidney: 108.2 skin: 0.7 KCNJ13 Kir1.4, Kir7.1, LCA16 ENSG00000115474 Potassium inwardly-rectifying channel, subfamily J, member 13 2 232766464-232776568 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 12 small intestine: 82.9 thyroid gland: 7.1 KCNJ16 BIR9, Kir5.1 ENSG00000153822 Potassium inwardly-rectifying channel, subfamily J, member 16 17 70053429-70135608 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level HPA059563 Uncertain Group enriched 7 kidney: 112.9;thyroid gland: 125.8 gallbladder: 17.8 KCNJ2 IRK1, Kir2.1, LQT7 ENSG00000123700 Potassium inwardly-rectifying channel, subfamily J, member 2 17 70168673-70180048 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA029109 Uncertain Mixed fallopian tube: 6.7 KCNJ3 GIRK1, KGA, Kir3.1 ENSG00000162989 Potassium inwardly-rectifying channel, subfamily J, member 3 2 154698299-154858352 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024231 Uncertain Group enriched 7 cerebral cortex: 13.5;duodenum: 7.8;heart muscle: 7.3;kidney: 6.9;prostate: 3.1;small intestine: 6.9 gallbladder: 1.1 KCNJ5 CIR, GIRK4, KATP1, Kir3.4, LQT13 ENSG00000120457 Potassium inwardly-rectifying channel, subfamily J, member 5 11 128891356-128921035 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014722, HPA017353, CAB022569 Supportive Group enriched 5 adrenal gland: 51.5;spleen: 12.6 placenta: 6.2 KCNJ6 BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2 ENSG00000157542 Potassium inwardly-rectifying channel, subfamily J, member 6 21 37607376-37916446 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level CAB012452 Uncertain Tissue enriched 6 cerebral cortex: 1.3 stomach: 0.2 KCNJ8 Kir6.1 ENSG00000121361 Potassium inwardly-rectifying channel, subfamily J, member 8 12 21764955-21775581 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031066 Uncertain Uncertain Nucleus but not nucleoli, Nuclear membrane, Cytoplasm Mixed heart muscle: 20.7 KCNK16 K2p16.1, TALK-1, TALK1 ENSG00000095981 Potassium channel, subfamily K, member 16 6 39314698-39322968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA016567 Uncertain Group enriched 7 duodenum: 1.6;pancreas: 3.5;stomach: 7.7 small intestine: 0.5 KCNK17 K2p17.1, TALK-2, TALK2, TASK-4, TASK4 ENSG00000124780 Potassium channel, subfamily K, member 17 6 39299001-39314553 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043892 Uncertain Mixed lung: 3.1 KCNK3 K2p3.1, TASK, TASK-1 ENSG00000171303 Potassium channel, subfamily K, member 3 2 26692690-26733420 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026658 Uncertain Tissue enhanced 0 adrenal gland: 70.8 placenta: 18.8 KCNK5 K2p5.1, TASK-2 ENSG00000164626 Potassium channel, subfamily K, member 5 6 39188973-39229450 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059148 Uncertain Uncertain Nucleus Mixed small intestine: 25.9 KCNK6 K2p6.1, TWIK-2 ENSG00000099337 Potassium channel, subfamily K, member 6 19 38319844-38329020 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB022637, HPA040184 Uncertain Uncertain Cytoplasm, Cytoskeleton (Actin filaments) Mixed endometrium: 14.1 KCNN2 hSK2, KCa2.2 ENSG00000080709 Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 5 114360945-114496640 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038221 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Tissue enhanced 0 adrenal gland: 16.2;liver: 10.1 prostate: 8.3 KCNN4 hIKCa1, hKCa4, hSK4, KCa3.1 ENSG00000104783 Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 19 43766533-43781257 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053841, HPA059622 Uncertain Uncertain Nucleus Tissue enhanced 0 salivary gland: 75.0 stomach: 28.4 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium voltage-gated channel, KQT-like subfamily, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supportive Tissue enhanced 0 adrenal gland: 84.9;thyroid gland: 79.6 stomach: 42.4 KCNQ2 BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2 ENSG00000075043 Potassium voltage-gated channel, KQT-like subfamily, member 2 20 63406039-63472638 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016642, HPA057112 Uncertain Uncertain Endoplasmic reticulum Group enriched 13 adrenal gland: 5.5;cerebral cortex: 21.5;testis: 10.2 prostate: 0.9 KCNQ3 EBN2, Kv7.3 ENSG00000184156 Potassium voltage-gated channel, KQT-like subfamily, member 3 8 132120859-132480953 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 11 cerebral cortex: 14.1 adrenal gland: 1.2 KCNQ4 DFNA2, Kv7.4 ENSG00000117013 Potassium voltage-gated channel, KQT-like subfamily, member 4 1 40784012-40840452 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018305 Uncertain Mixed smooth muscle: 1.3 KCNS1 Kv9.1 ENSG00000124134 Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 20 45092310-45101112 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 4.5;gallbladder: 2.4 testis: 0.8 KCNS2 Kv9.2 ENSG00000156486 Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 8 98427022-98432848 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051417 Uncertain Tissue enhanced 0 cerebral cortex: 3.7 urinary bladder: 0.8 KCNS3 Kv9.3 ENSG00000170745 Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 2 17877847-18361616 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA014864 Uncertain Uncertain Cytoplasm, Plasma membrane, Golgi apparatus Tissue enhanced 0 lung: 22.4;skeletal muscle: 22.2 placenta: 9.8 KCNT2 KCa4.2, SLICK, SLO2.1 ENSG00000162687 Potassium channel, subfamily T, member 2 1 196225779-196609225 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051218 Uncertain Tissue enhanced 0 ovary: 5.4 cerebral cortex: 2.2 LBP BPIFD2 ENSG00000129988 Lipopolysaccharide binding protein 20 38346356-38377023 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001508, CAB025905 Uncertain Uncertain Nucleus but not nucleoli, Vesicles Group enriched 5 adipose tissue: 41.2;liver: 181.2 appendix: 20.5 LHFPL5 DFNB67, dJ510O8.8, MGC33835, Tmhs ENSG00000197753 Lipoma HMGIC fusion partner-like 5 6 35805293-35833874 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA055110 Uncertain Tissue enhanced 0 cerebral cortex: 1.0 pancreas: 0.3 LRRC8A FLJ10337, KIAA1437, LRRC8 ENSG00000136802 Leucine rich repeat containing 8 family, member A 9 128882112-128918039 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016811 Uncertain Uncertain Nucleus but not nucleoli Expressed in all cerebral cortex: 43.4 LRRC8B KIAA0231, TA-LRRP ENSG00000197147 Leucine rich repeat containing 8 family, member B 1 89524836-89597864 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017950 Uncertain Uncertain Nucleus Mixed cerebral cortex: 21.1 LRRC8C AD158 ENSG00000171488 Leucine rich repeat containing 8 family, member C 1 89633072-89769903 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029347 Uncertain Uncertain Golgi apparatus Mixed smooth muscle: 13.8 LRRC8D FLJ10470, LRRC5 ENSG00000171492 Leucine rich repeat containing 8 family, member D 1 89821014-89936611 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014745 Uncertain Uncertain Nucleus but not nucleoli, Mitochondria Expressed in all lymph node: 22.1 LRRC8E FLJ23420 ENSG00000171017 Leucine rich repeat containing 8 family, member E 19 7888505-7902021 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020466 Uncertain Mixed skin: 4.4 MARVELD3 MRVLDC3 ENSG00000140832 MARVEL domain containing 3 16 71626161-71642114 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA043514, HPA045471 Uncertain Uncertain Vesicles, Cytoskeleton (Intermediate filaments) Tissue enhanced 0 small intestine: 25.0 duodenum: 23.8 MCL1 BCL2L3, Mcl-1 ENSG00000143384 Myeloid cell leukemia 1 1 150574551-150579738 Cancer-related genes, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002781, HPA008455, HPA031125, CAB068195 Uncertain Supportive Nucleus, Mitochondria Expressed in all bone marrow: 471.7 MCOLN1 ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1 ENSG00000090674 Mucolipin 1 19 7522626-7534009 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031763, CAB032637 Uncertain Supportive Plasma membrane, Cytoplasm Expressed in all spleen: 34.0 MCOLN2 FLJ36691, TRP-ML2, TRPML2 ENSG00000153898 Mucolipin 2 1 84925583-84997113 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level HPA019114, HPA048999 Uncertain Supportive Cytoskeleton (Intermediate filaments) Tissue enhanced 0 rectum: 12.8 tonsil: 11.1 MMD MMA, PAQR11 ENSG00000108960 Monocyte to macrophage differentiation-associated 17 55392613-55421992 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Expressed in all adipose tissue: 93.6 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supportive Group enriched 13 appendix: 176.9;lymph node: 562.2;spleen: 290.3;tonsil: 731.0 urinary bladder: 33.2 MS4A10 CD20L7, MS4A9 ENSG00000172689 Membrane-spanning 4-domains, subfamily A, member 10 11 60785348-60801305 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014778 Uncertain Group enriched 206 duodenum: 69.1;small intestine: 80.0 colon: 0.3 MS4A14 DKFZp434H092, FLJ32856, MS4A16, NYD-SP21 ENSG00000166928 Membrane-spanning 4-domains, subfamily A, member 14 11 60378530-60417756 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 9 testis: 46.3 spleen: 4.8 MYADM ENSG00000179820 Myeloid-associated differentiation marker 19 53866223-53876437 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056301 Uncertain Uncertain Nucleus but not nucleoli Expressed in all smooth muscle: 171.5 NALCN bA430M15.1, CanIon, VGCNL1 ENSG00000102452 Sodium leak channel, non-selective 13 101053776-101416492 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031889, HPA031890, HPA031958 Uncertain Uncertain Nucleus but not nucleoli Tissue enhanced 0 cerebral cortex: 14.3 adrenal gland: 3.9 NPPC CNP ENSG00000163273 Natriuretic peptide C 2 231921820-231926403 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA035362 Uncertain Tissue enhanced 0 prostate: 3.6 esophagus: 1.9 NSF SKD2 ENSG00000073969 N-ethylmaleimide-sensitive factor 17 46590669-46757464 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003154, CAB009324, CAB013645 Uncertain Supportive Cytoplasm Tissue enriched 6 cerebral cortex: 117.5 rectum: 20.9 ORAI1 CRACM1, FLJ14466, TMEM142A ENSG00000276045 ORAI calcium release-activated calcium modulator 1 12 121626550-121642677 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA016583, HPA061823 Uncertain Supportive Cytoplasm Expressed in all skin: 27.2 ORAI3 MGC13024, TMEM142C ENSG00000175938 ORAI calcium release-activated calcium modulator 3 16 30949066-30956461 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015022 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Expressed in all fallopian tube: 15.4 P2RX3 P2X3 ENSG00000109991 Purinergic receptor P2X, ligand-gated ion channel, 3 11 57338374-57370600 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA057776 Uncertain Tissue enhanced 0 heart muscle: 1.7;testis: 2.7 stomach: 0.4 P2RX4 P2X4 ENSG00000135124 Purinergic receptor P2X, ligand-gated ion channel, 4 12 121209857-121234106 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039494 Uncertain Uncertain Cytoskeleton (Actin filaments), Cytoplasm Mixed placenta: 23.9 P2RX7 MGC20089, P2X7 ENSG00000089041 Purinergic receptor P2X, ligand-gated ion channel, 7 12 121132819-121188032 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034968, HPA042013, HPA044141 Uncertain Mixed cerebral cortex: 11.3 PANX1 MRS1, PX1, UNQ2529 ENSG00000110218 Pannexin 1 11 94128928-94181972 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016930 Uncertain Supportive Plasma membrane Expressed in all urinary bladder: 11.7 PANX2 hPANX2, PX2 ENSG00000073150 Pannexin 2 22 50170731-50180294 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039117 Uncertain Tissue enhanced 0 cerebral cortex: 3.7 fallopian tube: 1.1 PANX3 Px3 ENSG00000154143 Pannexin 3 11 124611490-124620356 Predicted membrane proteins, Transporters Evidence at transcript level No evidence Evidence at transcript level Not detected testis: 0.1 PCDH15 CDHR15, DFNB23, USH1F ENSG00000150275 Protocadherin-related 15 10 53802771-55627942 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 8.6;cerebral cortex: 5.0 lung: 2.5 PDYN ADCA, PENKB, SCA23 ENSG00000101327 Prodynorphin 20 1978757-1994285 Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049841, HPA053342 Uncertain Tissue enriched 13 cerebral cortex: 31.4 testis: 2.4 PENK ENSG00000181195 Proenkephalin 8 56436674-56446734 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013138, CAB016390 Uncertain Group enriched 9 adrenal gland: 361.3;testis: 109.0 prostate: 26.5 PIEZO1 FAM38A, KIAA0233 ENSG00000103335 Piezo-type mechanosensitive ion channel component 1 16 88715343-88785211 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047185 Uncertain Expressed in all adipose tissue: 25.1 PIEZO2 C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771 ENSG00000154864 Piezo-type mechanosensitive ion channel component 2 18 10666483-11148762 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015986, HPA031974, HPA040616 Uncertain Mixed gallbladder: 7.5 PKD1 PBP, Pc-1, TRPP1 ENSG00000008710 Polycystic kidney disease 1 (autosomal dominant) 16 2088710-2135898 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB046448 Uncertain Expressed in all skin: 10.0 PKD1L1 PRO19563 ENSG00000158683 Polycystic kidney disease 1 like 1 7 47774652-47948491 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020422, HPA022424 Uncertain Mixed adipose tissue: 1.0 PKD1L3 ENSG00000277481 Polycystic kidney disease 1-like 3 16 71929538-71999978 Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level Not detected testis: 0.2 PKD2 Pc-2, PC2, PKD4, TRPP2 ENSG00000118762 Polycystic kidney disease 2 (autosomal dominant) 4 88007668-88077777 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004544, HPA015794, HPA055297 Uncertain Uncertain Cytoplasm Expressed in all endometrium: 55.3 PKD2L1 PCL, PKD2L, PKDL, TRPP3 ENSG00000107593 Polycystic kidney disease 2-like 1 10 100288154-100330486 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022621 Uncertain Tissue enhanced 0 spleen: 3.6 testis: 0.8 PLN CMD1P, PLB ENSG00000198523 Phospholamban 6 118548298-118560730 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005597, HPA026900 Supportive Uncertain Nucleus but not nucleoli Tissue enriched 6 heart muscle: 1171.9 skeletal muscle: 189.5 PLP2 A4, A4-LSB, MGC126187 ENSG00000102007 Proteolipid protein 2 (colonic epithelium-enriched) X 49171926-49175239 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042415 Uncertain Expressed in all skin: 268.9 PLTP BPIFE ENSG00000100979 Phospholipid transfer protein 20 45898621-45912155 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032873, HPA047207 Uncertain Uncertain Nucleoli, Golgi apparatus, Vesicles Expressed in all placenta: 394.1 PON1 ESA, PON ENSG00000005421 Paraoxonase 1 7 95297676-95324707 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001610 Uncertain Tissue enriched 53 liver: 111.7 adrenal gland: 2.1 PSAP GLBA, SAP1 ENSG00000197746 Prosaposin 10 71816298-71851369 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004426, CAB004647 Supportive Expressed in all spleen: 739.9 PSEN1 AD3, FAD, PS1, S182 ENSG00000080815 Presenilin 1 14 73136418-73223691 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006844, HPA030760, HPA067496 Supportive Uncertain Golgi apparatus, Nucleus, Cell Junctions Expressed in all rectum: 37.8 PSEN2 AD3L, AD4, PS2, STM2 ENSG00000143801 Presenilin 2 1 226870184-226896102 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013634, HPA038005 Supportive Nucleus Expressed in all testis: 14.2 PXMP4 PMP24 ENSG00000101417 Peroxisomal membrane protein 4, 24kDa 20 33702754-33720319 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050077 Uncertain Uncertain Vesicles Expressed in all lung: 13.7 REG3A HIP, PAP, PAP1, PBCGF, REG-III, REG3 ENSG00000172016 Regenerating islet-derived 3 alpha 2 79157003-79159753 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048334 Supportive Group enriched 40 duodenum: 4135.6;small intestine: 5518.0 stomach: 121.9 RHAG CD241, RH50A, SLC42A1 ENSG00000112077 Rh-associated glycoprotein 6 49605158-49636839 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055331 Uncertain Tissue enriched 50 bone marrow: 58.6 placenta: 1.1 RHBG SLC42A2 ENSG00000132677 Rh family, B glycoprotein (gene/pseudogene) 1 156369212-156385219 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA042726, HPA048489 Uncertain Uncertain Nucleus but not nucleoli Group enriched 5 kidney: 8.0;ovary: 7.1 skin: 1.5 RHCE CD240CE, RH ENSG00000188672 Rh blood group, CcEe antigens 1 25362249-25430192 Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 20 bone marrow: 29.8 testis: 1.4 RHCG C15orf6, PDRC2, RHGK, SLC42A3 ENSG00000140519 Rh family, C glycoprotein 15 89471398-89496613 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041874, HPA043317 Supportive Tissue enriched 6 esophagus: 2099.0 tonsil: 381.2 RHD CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI ENSG00000187010 Rh blood group, D antigen 1 25272393-25330445 Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 26 bone marrow: 11.5 placenta: 0.4 RYR1 CCO, MHS, MHS1, PPP1R137, RYR ENSG00000196218 Ryanodine receptor 1 (skeletal) 19 38433699-38587564 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056416 Supportive Uncertain Golgi apparatus, Vesicles, Cytoplasm Tissue enriched 20 skeletal muscle: 300.7 esophagus: 15.0 RYR2 ARVC2, ARVD2, VTSIP ENSG00000198626 Ryanodine receptor 2 (cardiac) 1 237042205-237833988 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020028 Uncertain Uncertain Nucleus but not nucleoli, Plasma membrane, Cytoplasm Tissue enriched 13 heart muscle: 54.4 cerebral cortex: 4.1 SAMM50 CGI-51, OMP85, TOB55, TRG-3, YNL026W ENSG00000100347 SAMM50 sorting and assembly machinery component 22 43955421-44010531 Mitochondrial proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034537 Supportive Supportive Mitochondria Expressed in all skeletal muscle: 58.2 SCN11A NaN, Nav1.9, SCN12A, SNS-2 ENSG00000168356 Sodium channel, voltage-gated, type XI, alpha subunit 3 38845769-38950561 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA036746, HPA036747 Uncertain Tissue enhanced 0 spleen: 3.3 placenta: 1.0 SCN1A FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI ENSG00000144285 Sodium channel, voltage-gated, type I, alpha subunit 2 165989160-166128013 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 36 cerebral cortex: 6.1;fallopian tube: 2.8;lung: 1.7 adipose tissue: 0.0 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage-gated, type II, alpha subunit 2 165239402-165392308 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supportive Tissue enriched 18 cerebral cortex: 31.4 kidney: 1.7 SCN4A HYKPP, HYPP, Nav1.4, SkM1 ENSG00000007314 Sodium channel, voltage-gated, type IV, alpha subunit 17 63938554-63972918 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053992 Uncertain Uncertain Nucleus but not nucleoli, Microtubule organizing center Group enriched 12 adipose tissue: 7.9;skeletal muscle: 35.7 thyroid gland: 1.8 SCN5A CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1 ENSG00000183873 Sodium channel, voltage-gated, type V, alpha subunit 3 38548057-38649673 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 35 heart muscle: 22.2 endometrium: 0.6 SCN8A CerIII, MED, NaCh6, Nav1.6, PN4 ENSG00000196876 Sodium channel, voltage gated, type VIII, alpha subunit 12 51590266-51812864 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 cerebral cortex: 11.2 testis: 1.7 SCN9A ETHA, Nav1.7, NE-NA, NENA, PN1 ENSG00000169432 Sodium channel, voltage-gated, type IX, alpha subunit 2 166195185-166375993 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013679, HPA061843 Uncertain Uncertain Plasma membrane, Cytoskeleton (Actin filaments) Mixed testis: 5.1 SCNN1A ENaCalpha, SCNN1 ENSG00000111319 Sodium channel, non-voltage-gated 1 alpha subunit 12 6346843-6377730 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA012743, HPA012939 Uncertain Mixed fallopian tube: 60.5 SCNN1B ENaCbeta ENSG00000168447 Sodium channel, non-voltage-gated 1, beta subunit 16 23278231-23381299 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015612 Uncertain Tissue enhanced 0 esophagus: 33.0 rectum: 28.8 SCNN1G ENaCgamma, SCNEG ENSG00000166828 Sodium channel, non-voltage-gated 1, gamma subunit 16 23182715-23216883 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 35.5 salivary gland: 8.8 SIDT1 FLJ20174, SID-1 ENSG00000072858 SID1 transmembrane family, member 1 3 113532296-113629578 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035862 Uncertain Mixed rectum: 8.0 SIDT2 CGI-40 ENSG00000149577 SID1 transmembrane family, member 2 11 117178733-117197445 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052352 Uncertain Expressed in all stomach: 33.5 SLC14A1 HsT1341, JK, RACH1, RACH2 ENSG00000141469 Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) 18 45724127-45752520 Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058353, HPA059570 Uncertain Supportive Vesicles Tissue enhanced 0 prostate: 46.1;urinary bladder: 35.1 gallbladder: 10.4 SLC14A2 HUT2, UT2 ENSG00000132874 Solute carrier family 14 (urea transporter), member 2 18 45212995-45683686 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 3.7 adipose tissue: 0.8 SLC31A1 COPT1, CTR1, hCTR1 ENSG00000136868 Solute carrier family 31 (copper transporter), member 1 9 113221562-113264492 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013810 Uncertain Expressed in all liver: 45.7 SLC31A2 COPT2, CTR2, hCTR2 ENSG00000136867 Solute carrier family 31 (copper transporter), member 2 9 113150942-113164137 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014861 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm, Cytoskeleton (Intermediate filaments) Tissue enriched 6 salivary gland: 192.0 adipose tissue: 33.9 SLC41A1 MgtE ENSG00000133065 Solute carrier family 41 (magnesium transporter), member 1 1 205789093-205813748 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA015138 Uncertain Expressed in all heart muscle: 53.1 SLC41A2 DKFZP434K0427 ENSG00000136052 Solute carrier family 41 (magnesium transporter), member 2 12 104802553-104958744 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038658 Uncertain Mixed liver: 36.2 SLC41A3 FLJ20473 ENSG00000114544 Solute carrier family 41, member 3 3 126006355-126101561 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA045847 Uncertain Expressed in all testis: 44.0 SLN MGC12301, MGC125854, MGC125855 ENSG00000170290 Sarcolipin 11 107707378-107719693 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 15 skeletal muscle: 2144.3 heart muscle: 141.2 SNAP23 HsT17016, SNAP23A, SNAP23B ENSG00000092531 Synaptosomal-associated protein, 23kDa 15 42491233-42545356 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001214, CAB037083, CAB037317 Supportive Supportive Plasma membrane Expressed in all lymph node: 66.5 SNAP25 bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25 ENSG00000132639 Synaptosomal-associated protein, 25kDa 20 10218830-10307418 FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000360, HPA001830 Supportive Uncertain Cytoplasm, Golgi apparatus, Cytoskeleton (Actin filaments), Nucleus, Nucleoli Tissue enriched 23 cerebral cortex: 916.5 adrenal gland: 39.9 SNAPIN BLOC1S7, SNAPAP ENSG00000143553 SNAP-associated protein 1 153658654-153661830 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046974 Uncertain Supportive Nucleoli, Golgi apparatus Expressed in all heart muscle: 28.0 SNCA alpha-synuclein, NACP, PARK1, PARK4, PD1 ENSG00000145335 Synuclein, alpha (non A4 component of amyloid precursor) 4 89724099-89838315 Cytoskeleton related proteins, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005459, CAB010877 Supportive Tissue enhanced 0 bone marrow: 166.7;cerebral cortex: 255.2 endometrium: 43.9 SPAG11B EDDM2B, EP2, EP2C, EP2D, HE2 ENSG00000164871 Sperm associated antigen 11B 8 7442684-7463674 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 5 fallopian tube: 0.5 adipose tissue: 0.0 SPPL2A IMP3, PSL2 ENSG00000138600 Signal peptide peptidase like 2A 15 50702266-50765808 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036062, HPA067304 Supportive Supportive Vesicles Expressed in all rectum: 80.9 STATH STR ENSG00000126549 Statherin 4 69995930-70002570 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044569 Supportive Tissue enhanced 0 ovary: 31.5;pancreas: 37.5;placenta: 33.7 heart muscle: 20.0 STIM1 D11S4896E, GOK ENSG00000167323 Stromal interaction molecule 1 11 3854527-4093210 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011088, HPA012123, CAB037128, CAB037288 Supportive Supportive Endoplasmic reticulum Expressed in all esophagus: 92.2 STX1A HPC-1, p35-1, STX1 ENSG00000106089 Syntaxin 1A (brain) 7 73699206-73719672 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008372 Supportive Tissue enriched 11 cerebral cortex: 83.6 bone marrow: 7.3 STX4 p35-2, STX4A ENSG00000103496 Syntaxin 4 16 31032889-31042975 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001330 Uncertain Supportive Plasma membrane Expressed in all skin: 30.4 SYT1 P65, SVP65, SYT ENSG00000067715 Synaptotagmin I 12 78863993-79452008 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008394, HPA064788 Supportive Tissue enriched 10 cerebral cortex: 272.2 smooth muscle: 28.3 TMBIM4 CGI-119, GAAP, LFG4, S1R, ZPRO ENSG00000155957 Transmembrane BAX inhibitor motif containing 4 12 66135846-66170072 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Expressed in all thyroid gland: 154.2 TMBIM6 BAXI1, BI-1, TEGT ENSG00000139644 Transmembrane BAX inhibitor motif containing 6 12 49707725-49764934 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017378 Uncertain Expressed in all kidney: 656.1 TMC6 EVER1, EVIN1, LAK-4P ENSG00000141524 Transmembrane channel-like 6 17 78110458-78132407 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051430 Uncertain Expressed in all spleen: 48.4 TMC8 EVER2, EVIN2 ENSG00000167895 Transmembrane channel-like 8 17 78130770-78142968 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA054429 Uncertain Group enriched 5 appendix: 40.2;bone marrow: 43.3;lymph node: 69.2;spleen: 63.2;tonsil: 37.1 lung: 9.7 TMEM63B C6orf110, dJ421H19.2, DKFZp434P0531 ENSG00000137216 Transmembrane protein 63B 6 44126914-44155519 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029249, HPA029250, HPA029251 Supportive Supportive Plasma membrane, Cytoskeleton (Actin filaments) Expressed in all lung: 37.3 TNFAIP2 B94, EXOC3L3 ENSG00000185215 Tumor necrosis factor, alpha-induced protein 2 14 103123442-103137439 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004598 Uncertain Expressed in all urinary bladder: 168.9 TOMM40 C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40 ENSG00000130204 Translocase of outer mitochondrial membrane 40 homolog (yeast) 19 44890569-44903689 Mitochondrial proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009156, HPA036231, HPA036232 Supportive Supportive Mitochondria, Cytoplasm Expressed in all esophagus: 14.3 TP53 LFS1, p53 ENSG00000141510 Tumor protein p53 17 7661779-7687550 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002973, CAB039238, CAB039239, HPA051244, CAB072876 Supportive Supportive Nucleus but not nucleoli Expressed in all tonsil: 40.2 TPCN1 FLJ20612, KIAA1169, TPC1 ENSG00000186815 Two pore segment channel 1 12 113221050-113298585 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039757 Uncertain Expressed in all heart muscle: 28.5 TPCN2 TPC2 ENSG00000162341 Two pore segment channel 2 11 69048897-69090604 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016561, HPA027080 Supportive Uncertain Nucleoli Expressed in all endometrium: 5.4 TRIM72 MG53 ENSG00000177238 Tripartite motif containing 72, E3 ubiquitin protein ligase 16 31214021-31226427 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023122, HPA054909 Supportive Uncertain Nucleus, Nucleoli Tissue enriched 11 skeletal muscle: 36.5 prostate: 3.3 TRPA1 ANKTM1 ENSG00000104321 Transient receptor potential cation channel, subfamily A, member 1 8 72019917-72075617 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026630 Uncertain Tissue enhanced 0 urinary bladder: 20.7 stomach: 7.3 TRPC1 HTRP-1 ENSG00000144935 Transient receptor potential cation channel, subfamily C, member 1 3 142724074-142807888 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009387, HPA021130 Supportive Uncertain Vesicles Mixed ovary: 12.0 TRPC3 ENSG00000138741 Transient receptor potential cation channel, subfamily C, member 3 4 121879027-121951754 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA037969 Uncertain Tissue enhanced 0 smooth muscle: 2.3 cerebral cortex: 1.1 TRPC5 PPP1R159 ENSG00000072315 Transient receptor potential cation channel, subfamily C, member 5 X 111774315-112082776 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 0.9 liver: 0.2 TRPC6 FSGS2, TRP6 ENSG00000137672 Transient receptor potential cation channel, subfamily C, member 6 11 101451564-101872562 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045098 Uncertain Tissue enhanced 0 placenta: 12.4 lung: 10.8 TRPM2 EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7 ENSG00000142185 Transient receptor potential cation channel, subfamily M, member 2 21 44350163-44443081 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030976, HPA035260 Uncertain Uncertain Nuclear membrane Mixed bone marrow: 12.4 TRPM3 GON-2, KIAA1616, LTRPC3 ENSG00000083067 Transient receptor potential cation channel, subfamily M, member 3 9 70529063-71446904 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 11.0 testis: 2.9 TRPM4 FLJ20041 ENSG00000130529 Transient receptor potential cation channel, subfamily M, member 4 19 49157741-49211836 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041169 Supportive Supportive Nucleus but not nucleoli, Plasma membrane Mixed prostate: 22.9 TRPM5 LTRPC5, MTR1 ENSG00000070985 Transient receptor potential cation channel, subfamily M, member 5 11 2404515-2423045 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA042115, HPA043315 Supportive Group enriched 5 colon: 0.6;duodenum: 1.6;small intestine: 1.4 thyroid gland: 0.2 TRPM6 CHAK2, FLJ22628, HOMG, HSH ENSG00000119121 Transient receptor potential cation channel, subfamily M, member 6 9 74722495-74888094 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007037 Uncertain Group enriched 6 colon: 11.1;duodenum: 5.1;rectum: 13.2;small intestine: 5.9 kidney: 1.4 TRPM7 CHAK1, LTRPC7, TRP-PLIK ENSG00000092439 Transient receptor potential cation channel, subfamily M, member 7 15 50552473-50686815 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035523, HPA052173 Uncertain Uncertain Nucleus but not nucleoli Expressed in all thyroid gland: 15.9 TRPV2 VRL, VRL-1, VRL1 ENSG00000187688 Transient receptor potential cation channel, subfamily V, member 2 17 16415542-16437003 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044993 Uncertain Expressed in all lung: 22.2 TRPV5 CaT2, ECAC1 ENSG00000127412 Transient receptor potential cation channel, subfamily V, member 5 7 142908101-142933808 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA063175 Uncertain Tissue enhanced 0 kidney: 0.8 testis: 0.2 TRPV6 CaT1, ECAC2 ENSG00000165125 Transient receptor potential cation channel, subfamily V, member 6 7 142871203-142885762 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA062644, HPA062864 Uncertain Uncertain Nucleus, Nucleoli Tissue enhanced 0 prostate: 24.7;salivary gland: 34.8 placenta: 18.1 TTYH1 ENSG00000167614 Tweety family member 1 19 54415219-54436900 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA023617, HPA050655 Supportive Group enriched 11 cerebral cortex: 84.2;fallopian tube: 25.8;testis: 27.2 pancreas: 4.1 TTYH2 C17orf29 ENSG00000141540 Tweety family member 2 17 74213514-74262020 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all cerebral cortex: 63.2 VAMP1 SYB1, VAMP-1 ENSG00000139190 Vesicle-associated membrane protein 1 (synaptobrevin 1) 12 6462237-6470987 FDA approved drug targets, Mitochondrial proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002779, CAB016119 Uncertain Expressed in all bone marrow: 34.5 VAMP2 SYB2, VAMP-2 ENSG00000220205 Vesicle-associated membrane protein 2 (synaptobrevin 2) 17 8159149-8163546 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all cerebral cortex: 241.6 VAMP8 EDB ENSG00000118640 Vesicle-associated membrane protein 8 2 85561562-85582031 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006882, CAB037132, CAB037147 Uncertain Expressed in all tonsil: 209.2 VDAC2 ENSG00000165637 Voltage-dependent anion channel 2 10 75210154-75231448 Mitochondrial proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043475 Supportive Supportive Mitochondria Expressed in all heart muscle: 43.5